Elutia Inc. (NASDAQ:ELUT - Get Free Report) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 108,200 shares, a growth of 7.4% from the September 30th total of 100,700 shares. Approximately 0.6% of the company's shares are short sold. Based on an average daily volume of 48,700 shares, the days-to-cover ratio is currently 2.2 days.
Analyst Ratings Changes
Separately, Cantor Fitzgerald reissued an "overweight" rating and set a $10.00 price objective on shares of Elutia in a research report on Friday, September 6th.
Check Out Our Latest Analysis on ELUT
Elutia Price Performance
Shares of ELUT stock traded down $0.01 during trading hours on Friday, hitting $3.19. The company had a trading volume of 10,672 shares, compared to its average volume of 42,543. The stock has a market capitalization of $108.65 million, a PE ratio of -1.12 and a beta of 0.73. The company's fifty day moving average is $3.79 and its 200 day moving average is $3.62. Elutia has a fifty-two week low of $1.33 and a fifty-two week high of $5.24.
Elutia (NASDAQ:ELUT - Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The company reported ($1.14) EPS for the quarter. The firm had revenue of $6.29 million during the quarter. Equities analysts forecast that Elutia will post -3.06 earnings per share for the current year.
Hedge Funds Weigh In On Elutia
Several institutional investors have recently bought and sold shares of the company. Arcus Capital Partners LLC acquired a new stake in shares of Elutia during the second quarter worth about $50,000. Renaissance Technologies LLC lifted its holdings in Elutia by 50.5% during the 2nd quarter. Renaissance Technologies LLC now owns 53,616 shares of the company's stock worth $266,000 after buying an additional 18,000 shares in the last quarter. Perkins Capital Management Inc. lifted its holdings in Elutia by 9.8% during the 3rd quarter. Perkins Capital Management Inc. now owns 856,552 shares of the company's stock worth $3,263,000 after buying an additional 76,450 shares in the last quarter. Nantahala Capital Management LLC boosted its position in Elutia by 8.8% in the 2nd quarter. Nantahala Capital Management LLC now owns 1,795,697 shares of the company's stock valued at $8,907,000 after buying an additional 145,697 shares during the period. Finally, AIGH Capital Management LLC grew its stake in shares of Elutia by 288.8% in the second quarter. AIGH Capital Management LLC now owns 1,697,316 shares of the company's stock worth $8,419,000 after acquiring an additional 1,260,750 shares in the last quarter. 74.03% of the stock is owned by institutional investors and hedge funds.
Elutia Company Profile
(
Get Free Report)
Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.
Further Reading
Before you consider Elutia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elutia wasn't on the list.
While Elutia currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
